[1. Anderlová K. et. al.: The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol. Res., 55(3), 277, 2006.10.33549/physiolres.93077916083306]Search in Google Scholar
[2. Bays H.E.: Adiposopathy is “sick fat” a cardiovascular disease? J. Am. Coll. Cardiol., 57(25), 2461, 2011.10.1016/j.jacc.2011.02.03821679848]Search in Google Scholar
[3. Blüher M., Mantzoros C.S.: From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism, 64(1), 131, 2015.10.1016/j.metabol.2014.10.01625497344]Search in Google Scholar
[4. Chen G.C., Qin L.Q., Ye J.K.: Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes. Rev., 15(2), 134, 2014.10.1111/obr.1208824102863]Search in Google Scholar
[5. Chen K. et. al.: Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat. Med., 12(4), 425, 2006.10.1038/nm137216582918]Search in Google Scholar
[6. Correia M.L., Rahmouni K.: Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes. Metab., 8(6), 603, 2006.10.1111/j.1463-1326.2005.00562.x17026484]Search in Google Scholar
[7. Dardeno T.A. et. al.: Leptin in human physiology and therapeutics. Front Neuroendocrinol., 31(3), 377, 2010.10.1016/j.yfrne.2010.06.002291673520600241]Search in Google Scholar
[8. Denroche H.C., Huynh F.K., Kieffer T.J.: The role of leptin in glucose homeostasis. J. Diabetes Investig., 3(2), 115, 2012.10.1111/j.2040-1124.2012.00203.x402072824843554]Search in Google Scholar
[9. Esteghamati A. et. al.: Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab. Syndr. Relat. Disord. 7(5), 447, 2009.10.1089/met.2008.010019419266]Search in Google Scholar
[10. Esteghamati A. et. al.: Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistant and obesity. Diabetes Res. Clin. Pract., 91(2), 154, 2011.10.1016/j.diabres.2010.11.00321122936]Search in Google Scholar
[11. Friedewald W.T., Levy R.I., Fredrickson D.S.: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18(6), 499, 1972.10.1093/clinchem/18.6.499]Search in Google Scholar
[12. Gui Y., Silha J.V., Murphy L.J.: Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes. Res., 12(9), 1481, 2004.10.1038/oby.2004.18515483213]Search in Google Scholar
[13. Kershaw E.E., Flier J.S.: Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab,. 89(6), 2548, 2004.10.1210/jc.2004-039515181022]Search in Google Scholar
[14. Lee J.M. et. al.: The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. Int. Med. Res., 37(6), 1803, 2009.10.1177/14732300090370061620146878]Search in Google Scholar
[15. Levey A.S. et. al.: Using standardized serum creatinine values in the modification of diet in the renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med., 145(4), 247, 2006.10.7326/0003-4819-145-4-200608150-0000416908915]Search in Google Scholar
[16. Ley S.H. et. al.: Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: the Sandy Lake Health and Diabetes Project. Diabetes Care, 31(7), 1410, 2008.10.2337/dc08-0036245366418339973]Search in Google Scholar
[17. Malecha-Jedraszek A. et. al.: Concentration of adiponectin in relation to insulin resistance in patients with type 2 diabetes. Ann. UMCS Sect. DDD, 24 (4), 73, 2011.]Search in Google Scholar
[18. Martos-Moreno G.Á. et. al.: Effect of weight loss on high-molecular weight adiponectin in obese children. Obesity (Silver Spring),18(12), 2288, 2010.10.1038/oby.2010.6820339359]Search in Google Scholar
[19. Matthews D.R. et. al.: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412, 1985.10.1007/BF002808833899825]Search in Google Scholar
[20. Menon V. et. al.: Factors associated with serum leptin in patients with chronic kidney disease. Clin. Nephrol., 61(3), 163, 2004.10.5414/CNP61163]Search in Google Scholar
[21. Olstad R. et. al.: Leptin in the General Population, Differences in Sex Hormones, Blood Lipids, Gender and Life Style Characteristics. The Open Behavioral Science Journal, 5, 8, 2011.10.2174/1874230001105010008]Search in Google Scholar
[22. Park H.K., Ahima R.S.: Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism, 64(1), 24, 2015.10.1016/j.metabol.2014.08.004426789825199978]Search in Google Scholar
[23. Paz-Filho G. et. al.: Leptin: molecular mechanisms, systemic proinflammatory effects, and clinical implications. Arq. Bras. Endocrinol. Metabol., 56(9), 597, 2012.10.1590/S0004-2730201200090000123329181]Search in Google Scholar
[24. Saginova E.A. et. al.: The role of leptin, adiponectin and insulinresistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients. Ter. Arkh., 83(6), 47, 2011.]Search in Google Scholar
[25. Sáinz N. et. al.: Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism, 64(1), 35, 2015.10.1016/j.metabol.2014.10.01525497342]Search in Google Scholar
[26. Silha J.V. et. al.: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol., 149(4), 331, 2003.10.1530/eje.0.149033114514348]Search in Google Scholar
[27. Söderberg S. et. al.: Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int. J. Obes. (Lond)., 31(7), 1126, 2007.10.1038/sj.ijo.080356117325688]Search in Google Scholar
[28. Sun Q. et. al.: Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study. Diabetes, 2010; 611, 59(3).]Search in Google Scholar
[29. Tokuyama Y. et. al.: Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism, 56(5), 693, 2007.10.1016/j.metabol.2006.12.01917445546]Search in Google Scholar
[30. Wang H., Luo W., Eitzman D.T.: Leptin in thrombosis and atherosclerosis. Curr. Pharm. Des., 20(4), 641, 2014.10.2174/1381612811319999001523688009]Search in Google Scholar
[31. Wannamethee S.G. et. al.: Adipokines and risk of type 2 diabetes in older men. Diabetes Care, 30(5), 1200, 2007.10.2337/dc06-241617322479]Search in Google Scholar
[32. Wannamethee S.G. et. al.: Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis, 191(2), 18, 2007.10.1016/j.atherosclerosis.2006.04.01216712853]Search in Google Scholar
[33. Welsh P. et. al.: Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care, 32(2), 308, 2009.10.2337/dc08-1458262869919001191]Search in Google Scholar
[34. Wolf G., Ziyadeh F.N.: Leptin and renal fibrosis. Contrib. Nephrol., 151, 175, 2006.]Search in Google Scholar
[35. World Health Organisation: Obesity: preventing and managing the global epidemic. Report of a WHO consultation, Genewa 1997.]Search in Google Scholar
[36. Zhou Y., Rui L.: Leptin signaling and leptin resistance. Front Med., 7(2), 207, 2013.10.1007/s11684-013-0263-5]Search in Google Scholar
[37. Zimmet P., Alberti K.G., Serrano Ríos M.: A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev. Esp. Cardiol., 58(12), 1371, 2005.10.1016/S1885-5857(06)60742-1]Search in Google Scholar
[38. Zuo H. et. al.: Association between serum leptin concentrations and insulin resistance: a population-based study from China. PLoS One, 8(1), 1, 2013.10.1371/journal.pone.0054615355175923349940]Search in Google Scholar